Not FDA-Approved. Scott T. Shepherd.
by Shepherd, Scott T; ProQuest Information and Learning Company.
Series: SIRS Enduring Issues 2005Article 12Health. Publisher: New Physician, 2004ISSN: 1522-323X;.Subject(s): Drugs -- Effectiveness | Drugs -- Off-label prescribing | Drugs -- Side effects | Drugs -- Testing | Pharmaceutical industry | United States Food and Drug AdmDDC classification: 050 Summary: "On a daily basis, pharmaceutical sales and detail reps meet with physicians to discuss their companies' various products. And while they're not allowed to promote an off-label use, they are allowed to dance on the line between promoting and providing information." (NEW PHYSICIAN) This article discusses off-label prescriptions, in which drug prescriptions are written for a use other than what the drug was approved for.| Item type | Current location | Call number | Status | Date due |
|---|---|---|---|---|
Books
|
High School - old - to delete | REF SIRS 2005 Health Article 12 (Browse shelf) | Available |
Articles Contained in SIRS Enduring Issues 2005.
Originally Published: Not FDA-Approved, May/June 2004; pp. 12+.
"On a daily basis, pharmaceutical sales and detail reps meet with physicians to discuss their companies' various products. And while they're not allowed to promote an off-label use, they are allowed to dance on the line between promoting and providing information." (NEW PHYSICIAN) This article discusses off-label prescriptions, in which drug prescriptions are written for a use other than what the drug was approved for.
Records created from non-MARC resource.
There are no comments for this item.